Dayananda A S, Yathirajan H S, Flörke Ulrich
Acta Crystallogr Sect E Struct Rep Online. 2012 Apr 1;68(Pt 4):o1180. doi: 10.1107/S1600536812012329. Epub 2012 Mar 24.
The title compound, C(17)H(19)F(2)N(2) (+)·C(7)H(5)O(3) (-)·C(7)H(6)O(3), is a co-crystal from 4-[bis-(4-fluoro-phen-yl)meth-yl]piperazin-1-ium, salicylate anion and salicylic acid in a 1:1:1 ratio. In addition to an intra-molecular O-H⋯O hydrogen bond, the crystal packing shows hydrogen bonds between the piperazinium cation and salicylate anion (N-H⋯O), as well as between the salicylic acid mol-ecule and anion (O-H⋯O), giving rise to a three-dimensional network.
标题化合物C(17)H(19)F(2)N(2) (+)·C(7)H(5)O(3) (-)·C(7)H(6)O(3)是由4-[双-(4-氟苯基)甲基]哌嗪-1-鎓、水杨酸根阴离子和水杨酸以1:1:1的比例形成的共晶体。除了分子内的O-H⋯O氢键外,晶体堆积还显示出哌嗪鎓阳离子与水杨酸根阴离子之间的氢键(N-H⋯O),以及水杨酸分子与阴离子之间的氢键(O-H⋯O),从而形成三维网络。